Rovor 2.5mg Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Rivaroxaban (2.5mg)
Overview Rovor 2.5mg Tablet
Anticoagulant medication, Rovor 2.5mg Tablet, thins the blood, preventing and treating blood clots. This helps lower the risk of stroke and heart attack, and inhibits clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent clots, it also mitigates clotting risk post-knee or hip replacement. Administration is independent of meals, but consistent daily timing optimizes efficacy. Long-term use, potentially lifelong, may be necessary; never discontinue or adjust dosage without physician consultation, as abrupt cessation significantly increases stroke, heart attack, and thrombosis risk. Lifestyle modifications – such as avoiding smoking, adopting a healthy diet, regular exercise, and weight management – further reduce clot risk. Increased bleeding (nosebleeds, bruising) is a common side effect; report any symptoms immediately. Contraindicated in patients with severe hepatic or renal impairment, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike other anticoagulants, routine PT-INR monitoring is unnecessary.
Primary Ingredients of Rovor 2.5mg Tablet
No text was provided to rephrase. Please provide the text you would like me to rewrite.
Uses of Rovor 2.5mg Tablet
Preventing and managing blood clots
Major Benefits of Rovor 2.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 2.5mg Rovor tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistency is key – take it at the same time each day.
Common Side effects of Rovor 2.5mg Tablet:
- Bleeding
How to use Rovor 2.5mg Tablet:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rovor 2.5mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Rovor 2.5mg Tablet works:
Xaclot 2.5mg tablets represent a new class of oral blood thinners. Their mechanism involves the inhibition of factor Xa, a key clotting agent, thus reducing the risk of dangerous blood clot development.
SAFETY ADVICE
AlcoholCAUTION
Using Rovor 2.5mg Tablets with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Rovor 2.5mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential benefits against any risks before prescribing this medication. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Employing Rovor 2.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Rovor 2.5mg Tablet, which can induce dizziness or fainting. Side effects from Rovor 2.5mg Tablet may impact your capacity to drive safely.
KidneyCAUTION
Patients with kidney impairment should use Rovor 2.5mg Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Rovor 2.5mg Tablets are contraindicated in patients with severe kidney disease.
LiverUNSAFE
Individuals with hepatic impairment should likely refrain from using Rovor 2.5mg tablets due to potential safety concerns. Medical advice is recommended.
What if you forget to take Rovor 2.5mg Tablet :
Should you forget to take a Rovor 2.5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rovor 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Morpholine- and thiophene-based derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | Xa Inhibitors for Oral Administration |



